Research related

Medicijnen en Levenswetenschappen

1. Pediatrics 100%
2. Neoplasms 83%
3. Precursor Cell Lymphoblastic Leukemia-Lymphoma 51%
4. Child 51%
5. Acute Myeloid Leukemia 42%
6. Survival 36%
7. Cancer Survivors 34%
8. Therapeutics 33%
9. Recurrence 31%
10. Wilms Tumor 29%
11. Glioma 29%
12. Neuroblastoma 26%
13. Melanoma 25%
14. Diffuse Intrinsic Pontine Glioma 23%
15. Drug Therapy 21%
16. Progression-Free Survival 20%
17. Mutation 20%
18. Leukemia 19%
19. Immunotherapy 19%
20. Netherlands 18%
21. Systematic Reviews 18%
22. Young Adult 18%
23. Hematopoietic Stem Cell Transplantation 18%
24. Cell Transplantation 17%
25. Glioblastoma 17%
26. Central Nervous System Neoplasms 15%
27. Guidelines 14%
28. Radiotherapy 14%
29. Cohort Studies 14%
30. DNA Methylation 13%
31. Genes 13%
32. Vincristine 13%
33. Population 13%
34. Paraganglioma 12%
35. Kidney 12%
36. T-Lymphocytes 12%
37. B-Lymphoid Precursor Cells 12%
38. Meta-Analysis 12%
39. Quality of Life 12%
40. Organoids 12%
41. Genome 11%
42. Atlases 11%
43. Neoplasm Metastasis 11%
44. Pheochromocytoma 11%
45. Brain Neoplasms 11%
46. Sleep 11%
47. Graft vs Host Disease 10%
48. Medulloblastoma 10%
49. Allogeneic Cells 10%
50. Sarcoma 10%
51. Dexamethasone 10%
52. Transplants 10%
53. Asparaginase 10%
54. Incidence 10%
55. Pharmacokinetics 10%
56. Pathology 9%
57. Kenya 9%
58. Transplantation 9%
59. Practice Guidelines 9%
60. Registries 9%
61. Peripheral Nervous System Diseases 9%
62. pembrolizumab 9%
63. Income 8%
64. Confidence Intervals 8%
65. Multicenter Studies 8%
66. Retrospective Studies 8%
67. Machine Learning 8%
68. Temozolomide 8%
69. Clofarabine 7%
70. Rhabdomyosarcoma 7%
71. Survival Rate 7%
72. Residual Neoplasm 7%
73. Fertility Preservation 7%
74. Fetal Blood 7%
75. Mortality 7%
76. Pandemics 7%
77. RNA Sequence Analysis 7%
78. Augmented Reality 7%
79. Pharmaceutical Preparations 7%
80. Parents 7%
81. Fatigue 6%
82. Methylation 6%
83. Astrocytoma 6%
84. Gene Fusion 6%
85. Survivors 6%
86. Bone Marrow 6%
87. Infratentorial Neoplasms 6%
88. Epigenomics 6%
89. Hodgkin Disease 6%
90. Biomarkers 6%
91. Typical Teratoid Rhabdoid Tumor 6%
92. Atypical Teratoid Tumor 6%
93. Indonesia 6%
94. Infections 6%
95. Randomized Controlled Trials 6%
96. Hematopoietic Stem Cells 5%
97. Brain 5%
98. Delivery of Health Care 5%
99. Clinical Trials 5%
100. Phenotype 5%